Shashank Rohatagi

2.7k total citations
83 papers, 2.2k citations indexed

About

Shashank Rohatagi is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Shashank Rohatagi has authored 83 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Pulmonary and Respiratory Medicine, 26 papers in Physiology and 22 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Shashank Rohatagi's work include Asthma and respiratory diseases (24 papers), Inhalation and Respiratory Drug Delivery (21 papers) and Pharmacogenetics and Drug Metabolism (11 papers). Shashank Rohatagi is often cited by papers focused on Asthma and respiratory diseases (24 papers), Inhalation and Respiratory Drug Delivery (21 papers) and Pharmacogenetics and Drug Metabolism (11 papers). Shashank Rohatagi collaborates with scholars based in United States, Germany and United Kingdom. Shashank Rohatagi's co-authors include Daniel E. Salazar, Hartmut Derendorf, Günther Hochhaus, H Möllmann, Jürgen Barth, Helen Kastrissios, Indravadan Patel, Jeanne Mendell, Jeffrey S. Barrett and Satoshi Kunitada and has published in prestigious journals such as Blood, CHEST Journal and Journal of Allergy and Clinical Immunology.

In The Last Decade

Shashank Rohatagi

83 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shashank Rohatagi United States 27 706 623 587 326 240 83 2.2k
Garrett Fitzgerald United States 25 943 1.3× 785 1.3× 496 0.8× 141 0.4× 159 0.7× 51 3.1k
Inge De Lepeleire United States 28 391 0.6× 480 0.8× 206 0.4× 82 0.3× 186 0.8× 80 2.4k
Zhimin Wang China 24 1.2k 1.7× 178 0.3× 721 1.2× 273 0.8× 204 0.8× 127 3.0k
Robert J. Noveck United States 27 499 0.7× 226 0.4× 161 0.3× 245 0.8× 71 0.3× 70 2.0k
Lutz Binder Germany 31 1.8k 2.5× 250 0.4× 289 0.5× 604 1.9× 186 0.8× 86 3.3k
Nigel S. Cook Switzerland 24 732 1.0× 544 0.9× 185 0.3× 41 0.1× 105 0.4× 63 2.6k
Chiara Giannarelli United States 34 1.3k 1.8× 383 0.6× 418 0.7× 45 0.1× 401 1.7× 88 3.1k
Jawahar L. Mehta United States 29 634 0.9× 320 0.5× 143 0.2× 49 0.2× 213 0.9× 95 2.4k
Lοukianos S. Rallidis Greece 29 1.5k 2.1× 350 0.6× 303 0.5× 80 0.2× 454 1.9× 172 3.3k
Cornelis Kramers Netherlands 26 262 0.4× 154 0.2× 146 0.2× 51 0.2× 88 0.4× 142 2.6k

Countries citing papers authored by Shashank Rohatagi

Since Specialization
Citations

This map shows the geographic impact of Shashank Rohatagi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shashank Rohatagi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shashank Rohatagi more than expected).

Fields of papers citing papers by Shashank Rohatagi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shashank Rohatagi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shashank Rohatagi. The network helps show where Shashank Rohatagi may publish in the future.

Co-authorship network of co-authors of Shashank Rohatagi

This figure shows the co-authorship network connecting the top 25 collaborators of Shashank Rohatagi. A scholar is included among the top collaborators of Shashank Rohatagi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shashank Rohatagi. Shashank Rohatagi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rohatagi, Shashank, et al.. (2016). Optimization of a Digital Medicine System in Psychiatry. The Journal of Clinical Psychiatry. 77(9). e1101–e1107. 25 indexed citations
2.
Wells, Thomas G., Douglas L. Blowey, Jeffrey L. Blumer, et al.. (2012). Pharmacokinetics of Olmesartan Medoxomil in Pediatric Patients with Hypertension. Pediatric Drugs. 14(6). 401–409. 8 indexed citations
3.
Salazar, Daniel E., Jingpu Shi, Shashank Rohatagi, et al.. (2011). The Use of Modeling and Simulation to Guide Clinical Development of Olmesartan Medoxomil in Pediatric Subjects. Clinical Pharmacology & Therapeutics. 91(2). 250–256. 8 indexed citations
4.
Riesmeyer, Jeffrey S., Daniel E. Salazar, Govinda J. Weerakkody, et al.. (2011). Relationship Between Exposure to Prasugrel Active Metabolite and Clinical Outcomes in the TRITON‐TIMI 38 Substudy. The Journal of Clinical Pharmacology. 52(6). 789–797. 41 indexed citations
5.
Rohatagi, Shashank, et al.. (2010). Correlation of Inhibition of Platelet Aggregation With Cardiovascular and Bleeding Outcomes in Acute Coronary Syndromes. The Journal of Clinical Pharmacology. 50(8). 904–913. 4 indexed citations
6.
Patel, Indravadan, Daniel E. Salazar, Shashank Rohatagi, et al.. (2010). Randomised, parallel-group, multicentre, multinational phase 2 study comparing edoxaban, an oral factor Xa inhibitor, with warfarin for stroke prevention in patients with atrial fibrillation. Thrombosis and Haemostasis. 104(9). 633–641. 260 indexed citations
7.
Rohatagi, Shashank, et al.. (2009). Is a Thorough QTc Study Necessary? The Role of Modeling and Simulation in Evaluating the QTc Prolongation Potential of Drugs. The Journal of Clinical Pharmacology. 49(11). 1284–1296. 38 indexed citations
8.
Wrishko, Rebecca E., C. Steven Ernest, David S. Small, et al.. (2009). Population Pharmacokinetic Analyses to Evaluate the Influence of Intrinsic and Extrinsic Factors on Exposure of Prasugrel Active Metabolite in TRITON‐TIMI 38. The Journal of Clinical Pharmacology. 49(8). 984–998. 66 indexed citations
9.
Rohatagi, Shashank, Helen Kastrissios, Kunihiro Sasahara, et al.. (2008). Pain relief model for a COX‐2 inhibitor in patients with postoperative dental pain. British Journal of Clinical Pharmacology. 66(1). 60–70. 5 indexed citations
10.
Paccaly, Anne, Annke Frick, Shashank Rohatagi, et al.. (2006). Pharmacokinetics of Otamixaban, a Direct Factor Xa Inhibitor, in Healthy Male Subjects: Pharmacokinetic Model Development for Phase 2/3 Simulation of Exposure. The Journal of Clinical Pharmacology. 46(1). 37–44. 25 indexed citations
11.
Diamant, Zuzana, Robert A. Baan, Benjamin A. Miller, et al.. (2005). Effect of a very late antigen‐4 receptor antagonist on allergen‐induced airway responses and inflammation in asthma. Clinical & Experimental Allergy. 35(8). 1080–1087. 22 indexed citations
12.
Rohatagi, Shashank, Sriram Krishnaswami, Marc Pfister, & Srikumar Sahasranaman. (2005). Model-Based Covariate Pharmacokinetic Analysis and Lack of Cortisol Suppression by the New Inhaled Corticosteroid Ciclesonide Using a Novel Cortisol Release Model. American Journal of Therapeutics. 12(5). 385–397. 34 indexed citations
13.
Crofts, Frances, Shashank Rohatagi, P. Brunel, et al.. (2004). Critical period for a teratogenic VLA‐4 antagonist: Developmental effects and comparison of embryo drug concentrations of teratogenic and non‐teratogenic VLA‐4 antagonists. Birth Defects Research Part B Developmental and Reproductive Toxicology. 71(2). 69–79. 13 indexed citations
14.
Rohatagi, Shashank, et al.. (2004). Pharmacokinetics, Pharmacodynamics, and Safety of a Lipid-Lowering Adenosine A1 Agonist, RPR749, in Healthy Subjects. American Journal of Therapeutics. 11(3). 175–189. 13 indexed citations
15.
Emmons, Gary T, et al.. (2003). Mass Balance Study of [14C]M100240, a Dual Angiotensin-Converting Enzyme/Neutral Endopeptidase Inhibitor, in Healthy Male Subjects. American Journal of Therapeutics. 10(5). 356–362. 2 indexed citations
16.
Meibohm, Bernd, Günther Hochhaus, Shashank Rohatagi, et al.. (1997). Dependency of Cortisol Suppression on the Administration Time of Inhaled Corticosteroids. The Journal of Clinical Pharmacology. 37(8). 704–710. 30 indexed citations
17.
Rohatagi, Shashank, Alan Bye, Christine Falcoz, et al.. (1996). Dynamic Modeling of Cortisol Reduction after Inhaled Administration of Fluticasone Propionate. The Journal of Clinical Pharmacology. 36(10). 938–941. 46 indexed citations
18.
Rohatagi, Shashank, et al.. (1996). Pharmacokinetic/Pharmacodynamic Modeling of Cortisol Suppression after Oral Administration of Fluocortolone. The Journal of Clinical Pharmacology. 36(4). 311–314. 9 indexed citations
19.
Möllmann, H, Günther Hochhaus, Shashank Rohatagi, Jürgen Barth, & Hartmut Derendorf. (1995). Pharmacokinetic/Pharmacodynamic Evaluation of Deflazacort in Comparison to Methylprednisolone and Prednisolone. Pharmaceutical Research. 12(7). 1096–1100. 50 indexed citations
20.
Hochhaus, Günther, et al.. (1995). Pharmacokinetics of Triamcinolone Acetonide After Intravenous, Oral, and Inhaled Administration. The Journal of Clinical Pharmacology. 35(3). 302–305. 97 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Garrett Fitzgerald Breakdown of academic impact, for papers by Inge De Lepeleire Breakdown of academic impact, for papers by Zhimin Wang Breakdown of academic impact, for papers by Robert J. Noveck Breakdown of academic impact, for papers by Lutz Binder Breakdown of academic impact, for papers by Nigel S. Cook Breakdown of academic impact, for papers by Chiara Giannarelli Breakdown of academic impact, for papers by Jawahar L. Mehta Breakdown of academic impact, for papers by Lοukianos S. Rallidis Breakdown of academic impact, for papers by Cornelis Kramers
Rankless by CCL
2026